Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
PHOENIX — Prosecutors have agreed to create a statewide database of officers whose truthfulness or honesty may be questionable. But an attorney with the American Civil Liberties Union says it appears ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...
Artificial Intelligence (AI) has achieved remarkable successes in recent years. It can defeat human champions in games like Go, predict protein structures with high accuracy, and perform complex tasks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback